Literature DB >> 10935503

Tumoral environment triggers transcript anomalies in established tumors: induction of altered gene expression and of aberrant, truncated and B2 repeat-containing gene transcripts.

P Rottiers1, M Desmedt, H Dooms, R Contreras, J Grooten.   

Abstract

In addition to eugenetic changes, cancerous cells exhibit extensive modifications in the expression levels of a variety of genes. The phenotypic switch observed after inoculation of T lymphoma cells into syngenic mice illustrates the active participation of tumoral environment in the induction of an aberrant gene expression pattern. To further substantiate this contribution, we performed polymerase chain reaction (PCR)-based subtraction suppression hybridization (SSH) to identify genes that are differentially expressed in tumor-derived EL4/13.3 cells compared to the same cells isolated from cultures. Besides a number of unknown genes, the subtracted library contained several known genes that have been reported to be expressed at increased levels in tumors and/or to contribute to carcinogenesis. Apart from clones representing translated transcripts, the subtracted library also contained a high number of clones representing B2 repeat elements, viz. short interspersed repetitive elements that are transcribed by RNA polymerase III. Northern blotting confirmed the induction of B2 transcripts in tumor tissue and also revealed induction of chimeric, B2 repeat-containing mRNA. The appearance of chimeric transcripts was accompanied by aberrant, shorter-than-full-length transcripts, specifically from upregulated genes. Accordingly, in addition to altered gene expression, tumoral environmental triggers constitute a potent mechanism to create an epigenetic diversity in cancers by inducing extensive transcript anomalies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10935503      PMCID: PMC1508124          DOI: 10.1038/sj.neo.7900070

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  Retroposons do jump: a B2 element recently integrated in an 18S rDNA gene.

Authors:  I Oberbäumer
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  Nucleotide sequence of small polyadenylated B2 RNA.

Authors:  D A Kramerov; S V Tillib; A P Ryskov; G P Georgiev
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

Review 3.  The origin and evolution of retroposons.

Authors:  J H Rogers
Journal:  Int Rev Cytol       Date:  1985

Review 4.  Metastasis-Associated genes and metastatic tumor progression.

Authors:  G L Nicolson; A S Moustafa
Journal:  In Vivo       Date:  1998 Nov-Dec       Impact factor: 2.155

5.  Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.

Authors:  E Stickeler; I B Runnebaum; V J Möbus; D G Kieback; R Kreienberg
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

6.  Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: equivalence of one species to B2 repetitive elements.

Authors:  D R Edwards; C L Parfett; D T Denhardt
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

7.  Aberrant splicing caused by the insertion of the B2 sequence into an intron of the complement C4 gene is the basis for low C4 production in H-2k mice.

Authors:  S Pattanakitsakul; J H Zheng; S Natsuume-Sakai; M Takahashi; M Nonaka
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

8.  Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage.

Authors:  E J Michaud; M J van Vugt; S J Bultman; H O Sweet; M T Davisson; R P Woychik
Journal:  Genes Dev       Date:  1994-06-15       Impact factor: 11.361

9.  Synthesis and processing of small B2 transcripts in mouse embryonal carcinoma cells.

Authors:  T S Bladon; C J Frégeau; M W McBurney
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

10.  Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican.

Authors:  M Yamagata; K Kimata
Journal:  J Cell Sci       Date:  1994-09       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.